The Present and Future of Screening in Breast Cancer Prevention

No abstract is available for this paper.

• Publication year

  2021

• Venue

  The Future of Prevention and Treatment of Breast Cancer

• Publication date

  Unknown publication date

• Fields of study

  Not labeled

• Identifiers
  DOI 10.1007/978-3-030-72815-1_9
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Improving cancer screening programs

  2020cited by this paper
• Detection and localization of surgically resectable cancers with a multi-analyte blood test

  2018cited by this paper
• Liquid Biopsies, What We Do Not Know (Yet).

  2017cited by this paper
• Cancer statistics, 2017

  2017cited by this paper
• Combined circulating tumor DNA and protein biomarker-based liquid biopsy for the earlier detection of pancreatic cancers

  2017cited by this paper
• Direct detection of early-stage cancers using circulating tumor DNA

  2017cited by this paper
• Mammographic breast density and breast cancer risk in a Mediterranean population: a nested case–control study in the EPIC Florence cohort

  2017cited by this paper
• Phylogenetic ctDNA analysis depicts early stage lung cancer evolution

  2017cited by this paper
• T-cell invigoration to tumour burden ratio associated with anti-PD-1 response

  2017cited by this paper
• The evidence base for circulating tumour DNA blood-based biomarkers for the early detection of cancer: a systematic mapping review

  2017cited by this paper
• Prostate Cancer Screening - A Perspective on the Current State of the Evidence.

  2017cited by this paper
• Predicting treatment resistance and relapse through circulating DNA.

  2017cited by this paper
• Detection of somatic mutations and HPV in the saliva and plasma of patients with head and neck squamous cell carcinomas

  2015cited by this paper
• Integrating Chemotherapy into the Management of Oligometastatic Colorectal Cancer: Evidence-Based Approach Using Clinical Trial Findings

  2015cited by this paper
• Abstract 5606: Detection of circulating tumor DNA in early and late stage human malignancies

  2014cited by this paper
• Blood-based analyses of cancer: circulating tumor cells and circulating tumor DNA.

  2014cited by this paper
• Cancer Genome Landscapes

  2013cited by this paper
• Evolutionary dynamics of cancer in response to targeted combination therapy

  2013cited by this paper
• Analysis of circulating tumor DNA to monitor metastatic breast cancer.

  2013cited by this paper
• Clinical Significance of the Genetic Landscape of Pancreatic Cancer and Implications for Identification of Potential Long-term Survivors

  2012cited by this paper
• Mammographic density and breast cancer risk: current understanding and future prospects

  2011cited by this paper
• Mammographic breast density and subsequent risk of breast cancer in postmenopausal women according to tumor characteristics.

  2011cited by this paper
• Breast density influences tumor subtypes and tumor aggressiveness.

  2011cited by this paper
• The Relative Importance of Genetics and Environment on Mammographic Density

  2009cited by this paper
• Comparative lesion sequencing provides insights into tumor evolution

  2008cited by this paper
• Mammographic density, breast cancer risk and risk prediction

  2007cited by this paper
• Histologic changes in the breast with menopausal hormone therapy use: correlation with breast density, estrogen receptor, progesterone receptor, and proliferation indices

  2007cited by this paper
• Unopposed estrogen therapy and the risk of invasive breast cancer.

  2006cited by this paper
• Effects of conjugated equine estrogens on breast cancer and mammography screening in postmenopausal women with hysterectomy.

  2006cited by this paper
• Mammographic density and the risk of breast cancer in Japanese women

  2005cited by this paper
• Regulation of aromatase activity by cytokines, PGE2 and 2-methoxyoestrone-3-O-sulphamate in fibroblasts derived from normal and malignant breast tissues.

  2005cited by this paper
• Estrogen Responsiveness and Control of Normal Human Breast Proliferation

  2004cited by this paper
• National cross sectional survey to determine whether the decision to delivery interval is critical in emergency caesarean section

  2004cited by this paper
• Tamoxifen and breast density in women at increased risk of breast cancer.

  2004cited by this paper
• Quantitative assessment of mammographic breast density: relationship with breast cancer risk.

  2004cited by this paper
• Molecular Basis of Breast Cancer

  2004cited by this paper
• Comparison of the effect of raloxifene and continuous-combined hormone therapy on mammographic breast density and breast tenderness in postmenopausal women.

  2003cited by this paper
• Breast cancer and hormone-replacement therapy: the Million Women Study

  2003cited by this paper
• Mammographic changes associated with raloxifene and tibolone therapy in postmenopausal women: a prospective study

  2002cited by this paper
• Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial.

  2002cited by this paper
• Digitized mammography: a clinical trial of postmenopausal women randomly assigned to receive raloxifene, estrogen, or placebo.

  2001cited by this paper
• Aromatase regulation and breast cancer

  2001cited by this paper
• RESPONSE: re: effect of hormone replacement therapy on breast cancer risk: estrogen versus estrogen plus progestin

  2000cited by this paper
• Pattern of distribution of cells positive for estrogen receptor α and progesterone receptor in relation to proliferating cells in the mammary gland

  1999cited by this paper
• Risks of breast and endometrial cancer after estrogen and estrogen–progestin replacement

  1999cited by this paper
• Variability and accuracy in mammographic interpretation using the American College of Radiology Breast Imaging Reporting and Data System.

  1998cited by this paper
• Control of aromatase activity in breast tumours: the role of the immune system.

  1997cited by this paper
• Fluorouracil plus Levamisole as Effective Adjuvant Therapy after Resection of Stage III Colon Carcinoma: A Final Report

  1995cited by this paper
• Mammographic features and breast cancer risk: effects with time, age, and menopause status.

  1995cited by this paper
• Quantitative classification of mammographic densities and breast cancer risk: results from the Canadian National Breast Screening Study.

  1995cited by this paper

• No citing papers are available for this paper.